Publications
Clinical Outcome Using The AnapnoGuard Device
The Use of a Novel Endotracheal Tube and
Airway Management System to Prevent
Complications in Lung Transplantation
Vivian Hernandez-Torres, Robert Ratzlaff, Mathew Thomas, Tathagat Narula, Archer K. Martin
A key component of the perioperative management of lung transplant recipients is the avoidance of airway and pulmonary complications in the immediate postoperative period. The AnapnoGuardTM AG100s (Hospitech Respiration Ltd, Kfar Saba, Israel), a novel endotracheal tube and ventilation management system, holds the potential to assist the care team in attenuating complications related to excessive cuff pressure, subglottic secretions, and endobronchial intubation. In this report, we describe the successful use of the AnapnoGuardTM AG100s system in the postoperative management of a lung transplant recipient.
CO2 driven endotracheal tube cuff control in critically ill patients: A randomized controlled study
Gennaro De Pascale* , Mariano Alberto Pennisi, Maria Sole Vallecoccia, Giuseppe Bello, Riccardo Maviglia, Luca Montini, Valentina Di Gravio, Salvatore Lucio Cutuli, Giorgio Conti, Massimo Antonelli
Maintaining the endotracheal tube (ETT) cuff appropriately inflated plays a crucial role in the management of incubated patients. Overinflation of the ETT cuff may compromise capil lary perfusion causing ischemic tracheal wall damage, ulcerations and tracheal stenosis. Conversely, suboptimal tracheal sealing, usually associated with Pcuff values below 20 cmH2O, may result in significant fluid leakage around the cuff, which is a crucial risk factor for ventilator associated pneumonia (VAP).